Close

XBiotech (XBIT) Announces Launch of S. Aureus Infections Therapy

May 28, 2015 8:04 AM EDT Send to a Friend
XBiotech (NASDAQ: XBIT) announced that the Food and Drug Administration (FDA) has lifted its clinical hold from the Company's IND ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login